The potential biotherapeutic targets of contrast-induced acute kidney injury

AS Cheng, X Li - International journal of molecular sciences, 2023 - mdpi.com
Contrast-induced acute kidney injury (CI− AKI) is manifested by an abrupt decline in kidney
function as a consequence of intravascular exposure to contrast media. With the increased …

Pharmacological agents for the prevention of colistin-induced nephrotoxicity

M Mirjalili, E Mirzaei, A Vazin - European Journal of Medical Research, 2022 - Springer
Background Colistin is a polymyxin antibiotic which has been used for treatment of Gram-
negative infections, but it was withdrawn due to its nephrotoxicity. However, colistin has …

Lrpap1 (RAP) inhibits proximal tubule clathrin mediated and clathrin independent endocytosis, ameliorating renal aminoglycoside nephrotoxicity

MC Wagner, RM Sandoval, SPS Yadav, SB Campos… - Kidney360, 2023 - journals.lww.com
Background Proximal tubules (PTs) are exposed to many exogenous and endogenous
nephrotoxins that pass through the glomerular filter. This includes many small molecules …

Understanding vancomycin nephrotoxicity augmented by β-lactams: a synthesis of endosymbiosis, proximal renal tubule mitochondrial metabolism, and β-lactam …

S Alosaimy, MJ Rybak, G Sakoulas - The Lancet Infectious Diseases, 2024 - thelancet.com
The recent understanding that hydrophobic β-lactams have greater affinity for organic anion
transporter-3 (OAT-3) of the proximal renal tubule could provide valuable insights for …

[HTML][HTML] Clinical and microbiologic efficacy and safety of imipenem/cilastatin/relebactam in complicated infections: a meta-analysis

S Sahra, A Jahangir, R Hamadi, A Jahangir… - Infection & …, 2021 - ncbi.nlm.nih.gov
Background Antimicrobial resistance is on the rise. The use of redundant and inappropriate
antibiotics is contributing to recurrent infections and resistance. Newer antibiotics with more …

Nephroprotective effects of cilastatin in people at risk of acute kidney injury: A systematic review and meta-analysis

D Acharya, F Ghanim, TG Harrison, TD Scory… - medRxiv, 2024 - medrxiv.org
ABSTRACT Rationale & Objective Cilastatin is an inhibitor of drug metabolism in the
proximal tubule that demonstrates nephroprotective effects in animals. It has been used in …

Cilastatin as a Potential Anti-Inflammatory and Neuroprotective Treatment in the Management of Glaucoma

MA Martínez-López, S Rubio-Casado… - International Journal of …, 2024 - mdpi.com
Glaucoma is a neurodegenerative disease that causes blindness. In this study, we aimed to
evaluate the protective role of cilastatin (CIL), generally used in the treatment of …

Alteration in acute kidney injury potential with the combination of vancomycin and imipenem-cilastatin/relebactam or piperacillin/tazobactam in a preclinical model

M He, E Souza, A Matvekas, RL Crass… - Antimicrobial Agents …, 2021 - Am Soc Microbiol
The risk of vancomycin (VAN)-associated acute kidney injury (AKI) may be altered with
combination regimens. The specific AKI risk when VAN is combined with imipenem …

[PDF][PDF] The therapeutic effect of Cilastatin on drug-induced nephrotoxicity: a new perspective.

T Becerir, O Tokgün, S Yuksel - European Review for Medical …, 2021 - europeanreview.org
OBJECTIVE: By creating nephrotoxicity models with cisplatin, vancomycin, and gentamicin
in HK-2 (human renal proximal tubule cell) and HEK293T (human embryonic kidney …

FKBP51, AmotL2 and IQGAP1 involvement in cilastatin prevention of cisplatin-induced tubular nephrotoxicity in rats

R González-Fernández, MÁ González-Nicolás… - Cells, 2022 - mdpi.com
The immunophilin FKBP51, the angiomotin AmotL2, and the scaffoldin IQGAP1 are
overexpressed in many types of cancer, with the highest increase in leucocytes from patients …